05/01/2019 | 3005664940 | Buderer Drug Company, Inc. | FMD-145 Letter | Ohio | Producer of Sterile Drug Products | 07/15/2019 |
05/01/2019 | 3005664940 | Buderer Drug Company, Inc | State Referral Letter | Ohio | Producer of Sterile Drug Products | 07/15/2019 |
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Tuesday, July 16, 2019
US FDA Compounding Oversight: Not As Bad As FDA Makes It Sound?
3 hours ago - HHS Inspector General paints a more positive picture of FDA's efforts to bring high-volume compounding into better regulatory control than the agency's own
"Taxpayers appear to be getting cheated in other ways, as compounders’ reimbursement claims to federal programs have skyrocketed. Medicare Part D spending on compounded topical creams rose by more than 3,400% between 2006 and 2015."
quoted from Compounding pharmacies need stricter federal oversight
By ANDREW L. YARROW
JULY 15, 2019
"State-level oversight of compounding pharmacies isn't enough to prevent illness and death from contaminated medicines. Greater federal oversight is needed."
21 hours ago - State-level oversight of compounding pharmacies isn't enough to prevent illness and death from contaminated medicines. Greater federal oversight is needed.
Thursday, July 11, 2019
But the authors say we could see similar trends in other drug categories where there is a big gap between list price and the net price paid by pharmacy benefit managers ... that employed a different ...
Subscribe to:
Posts (Atom)